Literature DB >> 3707113

Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.

M Bliss, M Mayersohn, T Arnold, J Logan, U F Michael, W Jones.   

Abstract

Cefamandole disposition kinetics were examined in six male subjects with renal impairment who were undergoing continuous ambulatory peritoneal dialysis. Creatinine clearance values ranged from less than 1 to 11 ml/min. Cefamandole was given as a 1-g intravenous dose infused over 30 min. Cefamandole concentrations were determined in serum, urine, and dialysis fluid by a high-performance liquid chromatographic method. The following average parameter values were obtained (range): half-life, 6.1 h (4.6 to 9.7); systemic clearance, 21.9 ml/min (8.4 to 35.5); renal clearance, 11.5 ml/min (0.03 to 22.3); dialysis clearance, 0.92 ml/min (0.7 to 1.3); nonrenal clearance, 12.2 ml/min (2.9 to 27.0); volume of distribution, 0.18 liter/kg (0.09 to 0.25); steady-state volume of distribution, 0.17 liter/kg (0.09 to 0.24). Approximately 5% of the dose was dialyzed (range, 2.8 to 8.3), indicating that there is no need to supplement a dosing regimen of cefamandole due to loss by dialysis. There was a positive correlation between creatinine clearance and the terminal elimination rate constant of cefamandole (r2 = 0.41) and cefamandole renal clearance (r2 = 0.83).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3707113      PMCID: PMC180460          DOI: 10.1128/AAC.29.4.649

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Pharmacological studies with cefamandole in human volunteers.

Authors:  B R Meyers; B Ribner; S Yancovitz; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

2.  Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.

Authors:  M J Ahern; F O Finkelstein; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

3.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

4.  Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

5.  Pharmacokinetics of cefamandole in the presence of renal failure in patients undergoing hemodialysis.

Authors:  G B Appel; H C Neu; M F Parry; M J Goldberger; G B Jacob
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

6.  Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.

Authors:  L O Gentry
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

7.  Cefamandole and cefazolin in the therapy of complicated urinary tract infections.

Authors:  U Hoyme; P O Madsen
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

8.  Cefamandole in treatment of peritonitis.

Authors:  H H Stone; B S Guest; C E Geheber; L D Kolb
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

9.  Pharmacokinetics of cefamandole in patients with renal failure.

Authors:  B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

10.  Pharmacokinetics of cefamandole in patients with normal and impaired renal function.

Authors:  H E Mellin; P G Welling; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.